DexCom, Inc. (DXCM)

114.29
NASDAQ
Prev Close 114.29
Day Low/High 0.00 / 0.00
52 Wk Low/High 72.03 / 156.16
Exchange NASDAQ
Shares Outstanding 90.00B
Market Cap 10.29B
Div & Yield N.A. (N.A)
Centers For Medicare & Medicaid Services (CMS) Classify Therapeutic Continuous Glucose Monitors (CGM) As "Durable Medical Equipment" Under Medicare Part B

Centers For Medicare & Medicaid Services (CMS) Classify Therapeutic Continuous Glucose Monitors (CGM) As "Durable Medical Equipment" Under Medicare Part B

DexCom, Inc. (NASDAQ:DXCM), the leader in continuous glucose monitoring (CGM) for people with diabetes, is pleased to announce the determination of a benefit category and coverage for CGM by CMS.

Short Interest In DexCom Decreases By 14%

Short Interest In DexCom Decreases By 14%

The most recent short interest data has been released for the 12/30/2016 settlement date, which shows a 1,165,825 share decrease in total short interest for DexCom Inc , to 7,210,719, a decrease of 13.92% since 12/15/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

DexCom: Look, but Don't Touch

DexCom: Look, but Don't Touch

The medical device company has been trading sideways for a long time and is likely to continue in the manner.

DexCom Reports Record Preliminary, Unaudited Revenue For The Fourth Quarter And Fiscal Year 2016 And Provides Initial 2017 Outlook

DexCom Reports Record Preliminary, Unaudited Revenue For The Fourth Quarter And Fiscal Year 2016 And Provides Initial 2017 Outlook

DexCom, Inc. (Nasdaq: DXCM) today reported that it achieved preliminary, unaudited revenue of approximately $168 million for the fourth quarter ended December 31, 2016, an estimated increase of 28% over the fourth quarter...

Analysts' Actions -- Medtronic, Nokia, Paccar, Verizon and More

Analysts' Actions -- Medtronic, Nokia, Paccar, Verizon and More

Here are Tuesday's top research calls, including downgrades for Medtronic, Nokia and Paccar, and an upgrade for Verizon.

FDA Approval Of Dexcom's Non-Adjunctive Indication Triggers A New Era In Diabetes Management

FDA Approval Of Dexcom's Non-Adjunctive Indication Triggers A New Era In Diabetes Management

Dexcom, Inc. (NASDAQ:DXCM), the leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that the U.

Analysts' Actions -- Bristol-Myers, Merck, United Technologies and More

Analysts' Actions -- Bristol-Myers, Merck, United Technologies and More

Here are Monday's top research calls, including upgrades for Bristol-Myers Squibb and United Technologies, and a downgrade for Merck.

DexCom Announces Upcoming Conference Presentation

DexCom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference: Kevin Sayer, President and Chief Executive Officer, will present an...

Short Interest In DexCom Jumps 20.4%

Short Interest In DexCom Jumps 20.4%

The most recent short interest data has been released for the 11/30/2016 settlement date, which shows a 1,271,741 share increase in total short interest for DexCom Inc , to 7,504,789, an increase of 20.40% since 11/15/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

'Mad Money' Lightning Round: Gilead Sciences, Celgene, Express Scripts

'Mad Money' Lightning Round: Gilead Sciences, Celgene, Express Scripts

Jim Cramer says he prefers Celgene to Gilead, and Walgreens Boots Alliance to Express Scripts.

Jim Cramer's 'Mad Money' Recap: Investors See Washington Going Pro-Business

Jim Cramer's 'Mad Money' Recap: Investors See Washington Going Pro-Business

Jim Cramer remains a fan of industrials, transports, banks and domestic oil producers.

DexCom Announces Upcoming Conference Presentation

DexCom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference: Steven Pacelli, Executive Vice President, Strategy and Corporate...

(Graphic: Business Wire)

(Graphic: Business Wire)

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, Dexcom, Inc.

DexCom, Inc. Reports Third Quarter 2016 Financial Results

DexCom, Inc. Reports Third Quarter 2016 Financial Results

DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended September 30, 2016.

Analysts' Actions -- Chevron, Home Depot, Macy's, Nike and More

Analysts' Actions -- Chevron, Home Depot, Macy's, Nike and More

Here are Monday's top research calls, including upgrades for Chevron, Macy's and Qualcomm, and downgrades for Home Depot, Lowe's, Exxon Mobil, Nike and Nordstrom.

NXPI, AAPL, C: Jim Cramer's Views

NXPI, AAPL, C: Jim Cramer's Views

Cramer shares his views on takeover talks. NXP Semiconductor, Apple and Citigroup are among the stocks discussed.

4 Short Stock Trades You Should Be Watching

4 Short Stock Trades You Should Be Watching

Here are four stocks that are trending lower in this precarious market.

Cramer: Demand Lifts Defense, Aerospace, Cyber-Security, Regional Bank Stocks

Cramer: Demand Lifts Defense, Aerospace, Cyber-Security, Regional Bank Stocks

But several airline and retail stocks are proving highly volatile.

DexCom Announces Upcoming Conference Presentations

DexCom Announces Upcoming Conference Presentations

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conferences: Kevin Sayer, President and Chief Executive Officer, will present an...

DexCom Schedules Third Quarter 2016 Earnings Release And Conference Call For November 1, 2016 At 4:30 P.m. Eastern Time

DexCom Schedules Third Quarter 2016 Earnings Release And Conference Call For November 1, 2016 At 4:30 P.m. Eastern Time

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2016 financial results after market close on Tuesday, November 1, 2016.

DexCom Announces Upcoming Conference Presentation

DexCom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference: Matt Dolan, Senior Director of Corporate Affairs, will present an...

Jim Cramer's Top Takeaways: Johnson Controls, DexCom

Jim Cramer's Top Takeaways: Johnson Controls, DexCom

Cramer says Johnson Controls has a number of catalysts going for it starting with its forthcoming split into three companies.

Jim Cramer's 'Mad Money' Recap: Whoever Uses the Internet Best, Wins

Jim Cramer's 'Mad Money' Recap: Whoever Uses the Internet Best, Wins

The Internet is a beast. If you don't feed it, it will eat you alive, Cramer says.

Watch Out: Barbarians At The Gate For DexCom (DXCM)

Watch Out: Barbarians At The Gate For DexCom (DXCM)

Trade-Ideas LLC identified DexCom (DXCM) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

DexCom Announces Upcoming Conference Presentations

DexCom Announces Upcoming Conference Presentations

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conferences: Steven Pacelli, Executive Vice President, Strategy and Corporate...

DexCom, Inc. Reports Second Quarter 2016 Financial Results

DexCom, Inc. Reports Second Quarter 2016 Financial Results

DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended June 30, 2016.

Barbarian At The Gate: DexCom (DXCM)

Barbarian At The Gate: DexCom (DXCM)

Trade-Ideas LLC identified DexCom (DXCM) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

FDA Posts Briefing Documents Ahead Of Advisory Committee Meeting

FDA Posts Briefing Documents Ahead Of Advisory Committee Meeting

Dexcom, Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that the US Food and Drug Administration (FDA) published the briefing documents ahead of the July 21,...

Insider Trading Alert - MTSI, DXCM And RMD Traded By Insiders

Insider Trading Alert - MTSI, DXCM And RMD Traded By Insiders

Stocks with insider trader activity include MTSI, DXCM and RMD

DexCom Schedules Second Quarter 2016 Earnings Release And Conference Call For August 2, 2016 At 4:30 P.m. Eastern Time

DexCom Schedules Second Quarter 2016 Earnings Release And Conference Call For August 2, 2016 At 4:30 P.m. Eastern Time

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2016 financial results after market close on Tuesday, August 2, 2016.

TheStreet Quant Rating: D+ (Sell)